Activity of ZD1839 (gefitinib, Iressa™) in previously treated patients with recurrent and advanced non-small-cell lung cancer

Angelia D. Gibson; Mark Socinski; Chandra P. Belani; Vinay K. Jain

doi:10.1016/S1525-7304(11)70679-9

Activity of ZD1839 (gefitinib, Iressa™) in previously treated patients with recurrent and advanced non-small-cell lung cancer

Angelia D. Gibson
, Mark Socinski
, Chandra P. Belani
, Vinay K. Jain

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	23-25
Number of pages	3
Journal	Clinical Lung Cancer
Volume	4
Issue number	1
DOIs	https://doi.org/10.1016/S1525-7304(11)70679-9
State	Published - Jul 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

Access to Document

10.1016/S1525-7304(11)70679-9

Cite this

@article{b9e142f9978546f8b732b877be94e6d9,

title = "Activity of ZD1839 (gefitinib, Iressa{\texttrademark}) in previously treated patients with recurrent and advanced non-small-cell lung cancer",

author = "Gibson, \{Angelia D.\} and Mark Socinski and Belani, \{Chandra P.\} and Jain, \{Vinay K.\}",

year = "2002",

month = jul,

doi = "10.1016/S1525-7304(11)70679-9",

language = "English (US)",

volume = "4",

pages = "23--25",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Activity of ZD1839 (gefitinib, Iressa™) in previously treated patients with recurrent and advanced non-small-cell lung cancer

AU - Gibson, Angelia D.

AU - Socinski, Mark

AU - Belani, Chandra P.

AU - Jain, Vinay K.

PY - 2002/7

Y1 - 2002/7

UR - https://www.scopus.com/pages/publications/0036638457

UR - https://www.scopus.com/pages/publications/0036638457#tab=citedBy

U2 - 10.1016/S1525-7304(11)70679-9

DO - 10.1016/S1525-7304(11)70679-9

M3 - Article

C2 - 14653872

AN - SCOPUS:0036638457

SN - 1525-7304

VL - 4

SP - 23

EP - 25

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 1

ER -

Activity of ZD1839 (gefitinib, Iressa™) in previously treated patients with recurrent and advanced non-small-cell lung cancer

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this